meRfi®-GM
Diabetic neuropathy
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The global prevalence of diabetes underscores the substantial number of individuals at risk for chronic complications, with diabetic neuropathy (DN) being the most prevalent among them.
About 50% of individuals with type 1 diabetes and type 2 diabetes develop diabetic neuropathy
The primary clinical manifestations of diabetic neuropathy include:
- Spontaneous tingling
- Hyperalgesia and allodynia
- Sensory loss
Viana et al. 2025 Benef Microbes Mar 28: 1-15
…